📰 Human Use News
Page 86 - Human Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Human Use. Real-time updates on events, politics, business and more.
February 27, 2023
If approved company’s prostate cancer therapy will be the first dual-action tablet available in EU - News - PharmaTimes
February 27, 2023
ORION CORPORATION PRESS RELEASE 27 February 2023 at 9:00 EET Darolutamide receives approval for additional prostate cancer indication in Japan Darolutamide approved for metastatic
February 27, 2023
(RTTNews) - AbbVie (ABBV) said Monday that the European Medicines Agencys (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended...
February 27, 2023
Orion has received approval from the MHLW in Japan for darolutamide plus ADT along with docetaxel to treat metastatic prostate cancer.
February 27, 2023
A PEGylated enzyme replacement therapy for Fabry disease has received a positive opinion from the EMA's human medicines committee.
February 24, 2023
Harmony Biosciences provided business updates, noting continued strong momentum for its commercial business of WAKIX.
February 24, 2023
Tibsovo® (ivosidenib tablets) is the first IDH1 inhibitor recommended for approval in EuropeThe positive CHMP opinion is based on clinical data from the AGILE (in AML) and ClarIDHy (in CCA)
February 24, 2023
PARIS, Feb. 24, 2023 /PRNewswire/ -- Servier, a global pharmaceutical company, today announced that the...
February 24, 2023
Operator: Good morning everyone. My name is Todd and I will be your conference operator today.
February 24, 2023
Recent studies show that Merck's drug is less effective than early trials indicated